136 related articles for article (PubMed ID: 35711683)
1. Derivation, internal validation, and recalibration of a cardiovascular risk score for Latin America and the Caribbean (Globorisk-LAC): A pooled analysis of cohort studies.
Cohorts Consortium of Latin America and the Caribbean (CC-LAC)
Lancet Reg Health Am; 2022 May; 9():None. PubMed ID: 35711683
[TBL] [Abstract][Full Text] [Related]
2. Impact of common cardio-metabolic risk factors on fatal and non-fatal cardiovascular disease in Latin America and the Caribbean: an individual-level pooled analysis of 31 cohort studies.
Cohorts Consortium of Latin America and the Caribbean (CC-LAC)
Lancet Reg Health Am; 2021 Dec; 4():None. PubMed ID: 34957436
[TBL] [Abstract][Full Text] [Related]
3. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys.
Hajifathalian K; Ueda P; Lu Y; Woodward M; Ahmadvand A; Aguilar-Salinas CA; Azizi F; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano D; Msyamboza KP; Oh K; Rodríguez-Artalejo F; Rojas-Martinez R; Shaw JE; Stevens GA; Tolstrup J; Zhou B; Salomon JA; Ezzati M; Danaei G
Lancet Diabetes Endocrinol; 2015 May; 3(5):339-55. PubMed ID: 25819778
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Disease Prognostic Models in Latin America and the Caribbean: A Systematic Review.
Carrillo-Larco RM; Altez-Fernandez C; Pacheco-Barrios N; Bambs C; Irazola V; Miranda JJ; Danaei G; Perel P
Glob Heart; 2019 Mar; 14(1):81-93. PubMed ID: 31036306
[TBL] [Abstract][Full Text] [Related]
5. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.
Ueda P; Woodward M; Lu Y; Hajifathalian K; Al-Wotayan R; Aguilar-Salinas CA; Ahmadvand A; Azizi F; Bentham J; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ferguson TS; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano DJ; Margozzini P; Msyamboza KP; Mutungi G; Oh K; Oum S; Rodríguez-Artalejo F; Rojas-Martinez R; Valdivia G; Wilks R; Shaw JE; Stevens GA; Tolstrup JS; Zhou B; Salomon JA; Ezzati M; Danaei G
Lancet Diabetes Endocrinol; 2017 Mar; 5(3):196-213. PubMed ID: 28126460
[TBL] [Abstract][Full Text] [Related]
6. Laboratory-based and office-based Globorisk scores to predict 10-year risk of cardiovascular diseases among Iranians: results from the Fasa PERSIAN cohort.
Jahangiry L; Dehghan A; Farjam M; Aune D; Rezaei F
BMC Med Res Methodol; 2022 Nov; 22(1):305. PubMed ID: 36435774
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran.
Fahimfar N; Fotouhi A; Mansournia MA; Malekzadeh R; Sarrafzadegan N; Azizi F; Mansourian M; Sepanlou SG; Emamian MH; Hadaegh F; Roohafza H; Hashemi H; Poustchi H; Pourshams A; Samavat T; Sharafkhah M; Talaei M; Van Klaveren D; Steyerberg EW; Khalili D
Int J Health Policy Manag; 2022 Feb; 11(2):210-217. PubMed ID: 32668896
[TBL] [Abstract][Full Text] [Related]
8. Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice.
Schoofs MC; Akkermans RP; de Grauw WJ; Schalk BW; van Dis I; Tjin-A-Ton J; Bischoff EW; Biermans MC
Br J Gen Pract; 2023 Jan; 73(726):e24-e33. PubMed ID: 36443066
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
[No Abstract] [Full Text] [Related]
10. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
[No Abstract] [Full Text] [Related]
11. Comparison of the performance of cardiovascular risk prediction tools in rural India: the Rishi Valley Prospective Cohort Study.
Birhanu MM; Zengin A; Evans RG; Joshi R; Kalyanram K; Kartik K; Danaei G; Barr E; Riddell MA; Suresh O; Srikanth VK; Arabshahi S; Thomas N; Thrift AG
Eur J Prev Cardiol; 2024 Apr; 31(6):723-731. PubMed ID: 38149975
[TBL] [Abstract][Full Text] [Related]
12. A comparative assessment between Globorisk and WHO cardiovascular disease risk scores: a population-based study.
Dehghan A; Rezaei F; Aune D
Sci Rep; 2023 Aug; 13(1):14229. PubMed ID: 37648706
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Minhas R; Sheikh A; Brindle P
BMJ; 2008 Jun; 336(7659):1475-82. PubMed ID: 18573856
[TBL] [Abstract][Full Text] [Related]
15. Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world.
Joseph P; Yusuf S; Lee SF; Ibrahim Q; Teo K; Rangarajan S; Gupta R; Rosengren A; Lear SA; Avezum A; Lopez-Jaramillo P; Gulec S; Yusufali A; Chifamba J; Lanas F; Kumar R; Mohammadifard N; Mohan V; Mony P; Kruger A; Liu X; Guo B; Zhao W; Yang Y; Pillai R; Diaz R; Krishnapillai A; Iqbal R; Yusuf R; Szuba A; Anand SS;
Heart; 2018 Apr; 104(7):581-587. PubMed ID: 29066611
[TBL] [Abstract][Full Text] [Related]
16. Application of a Lifestyle-Based Score to Predict Cardiovascular Risk in African Americans: The Jackson Heart Study.
Sotos-Prieto M; Zhao S; Kline D; Brock G; Gooding H; Mattei J; Rodriguez-Artalejo F; Min YI; Rimm EB; Tucker KL; Joseph JJ
J Clin Med; 2021 May; 10(11):. PubMed ID: 34067473
[TBL] [Abstract][Full Text] [Related]
17. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort.
Fox ER; Samdarshi TE; Musani SK; Pencina MJ; Sung JH; Bertoni AG; Xanthakis V; Balfour PC; Shreenivas SS; Covington C; Liebson PR; Sarpong DF; Butler KR; Mosley TH; Rosamond WD; Folsom AR; Herrington DM; Vasan RS; Taylor HA
JAMA Cardiol; 2016 Apr; 1(1):15-25. PubMed ID: 27437649
[TBL] [Abstract][Full Text] [Related]
19. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
Solomon DH; Greenberg J; Curtis JR; Liu M; Farkouh ME; Tsao P; Kremer JM; Etzel CJ
Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
